Skip to main content
. 2021 Sep 28;48(2):395–404. doi: 10.1093/schbul/sbab115

Table 1.

Demographics of Symptom-Based Remitters and Nonremitters in Both the NAPLS3a and NAPLS2 Samples

NAPLS3 NAPLS2
Remitters Nonremitters Test Statistic P Value Remitters Nonremitters Test Statistic P Value
N Mean (SD) N Mean (SD) t/χ 2 (df) N Mean (SD) N Mean (SD) t/χ 2 (df)
Age 75 18.4 (4.06) 493 18.4 (4.02) t(97.3) = −0.06 .94 94 18.3 (4.35) 459 18.6 (4.25) t(131.9) = 0.54 .59
Sex, no. (%) female 75 34 (45.3%) 493 225 (45.6%) χ 2(2) = 0.0025 .96 94 34 (36%) 459 202 (44%) χ 2(2) = 1.96 .16
Race, no. (%) nonwhite 75 28 (37.3%) 493 221 (44.8%) χ 2(2) = 1.49 .22 94 42 (44.7%) 459 184 (40.1%) χ 2(2) = 0.68 .41
Ethnicity, no. (%) Hispanic 75 15 (20%) 493 98 (19.9%) χ 2(2) = 0.0006 .98 94 23 (24.5%) 459 74 (16.1%) χ 2(2) = 3.76 .052
Years of education 75 11.5 (3.16) 493 11.6 (3.09) t(96.7) = 0.20 .84 94 11.4 (3.23) 459 11.3 (2.75) t(122.1) = −0.09 .92
Baseline positive symptoms 75 11.7 (3.63) 493 13.0 (3.23) t(92.6) = 3.08 .003 94 9.6 (4.28) 459 12.3 (3.63) t(121.9) = 5.75 <.001
Baseline functioning 75 52.3 (11.8) 493 51.3 (12.29) t(99.9) = −0.63 .53 94 49.5 (11.12) 459 48.4 (10.74) t(130.9) = −0.88 .38

Bold values indicate significant differences between remitters and non-remitters at the significance level of p = 0.05.

aNAPLS = North American Prodrome Longitudinal Study.